| Dr Raid Abu-awwad, MD | |
|
3311 E Murdock St, Wichita, KS 67208-3054 | |
| (316) 689-9325 | |
| (316) 689-9363 |
| Full Name | Dr Raid Abu-awwad |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 17 Years |
| Location | 3311 E Murdock St, Wichita, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386945392 | NPI | - | NPPES |
| 201132140A | Medicaid | KS | |
| 003719467 | Other | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 04-38736 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Via Christi Hospital-wichita | Wichita, KS | Hospital |
| Via Christi Hospital Wichita St Teresa, Inc | Wichita, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ascension Medical Group Via Christi, Pa | 2961314497 | 177 |
| Ascension Via Christi Hospitals Wichita Inc | 5799696944 | 70 |
News Archive
The findings prompt the researchers to consider whether car design might need to change to afford greater protection to the considerable proportion of obese people in the population - currently around a third of all US adults.
A new study by researchers at the University of Eastern Finland shows for the first time that blood-based measurement of glial fibrillary acidic protein (GFAP) enables distinguishing patients with frontotemporal dementia from those with primary psychiatric disorders or healthy individuals.
Los Angeles Association of Health Underwriters announces its annual Health Insurance Awareness Week. This week is set aside to perform outreach to the community in the form of health awareness and to the importance of the role of the health insurance agent.
Boston-based Veritas Genetics, a pioneer in accessible genetic screening for disease prevention and early detection, received its first European CE mark approval for the company's hereditary breast and ovarian cancer genetic screening test, myBRCA. Veritas introduced myBRCA, which sequences BRCA1 and BRCA2 genes using proprietary gene-targeting technology and Next Generation Sequencing, in North America in May 2015.
› Verified 1 days ago
| Entity Name | Ascension Medical Group Via Christi, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063453991 PECOS PAC ID: 2961314497 Enrollment ID: O20031104000089 |
News Archive
The findings prompt the researchers to consider whether car design might need to change to afford greater protection to the considerable proportion of obese people in the population - currently around a third of all US adults.
A new study by researchers at the University of Eastern Finland shows for the first time that blood-based measurement of glial fibrillary acidic protein (GFAP) enables distinguishing patients with frontotemporal dementia from those with primary psychiatric disorders or healthy individuals.
Los Angeles Association of Health Underwriters announces its annual Health Insurance Awareness Week. This week is set aside to perform outreach to the community in the form of health awareness and to the importance of the role of the health insurance agent.
Boston-based Veritas Genetics, a pioneer in accessible genetic screening for disease prevention and early detection, received its first European CE mark approval for the company's hereditary breast and ovarian cancer genetic screening test, myBRCA. Veritas introduced myBRCA, which sequences BRCA1 and BRCA2 genes using proprietary gene-targeting technology and Next Generation Sequencing, in North America in May 2015.
› Verified 1 days ago
| Entity Name | Ascension Via Christi Hospitals Wichita Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871589333 PECOS PAC ID: 5799696944 Enrollment ID: O20031118000404 |
News Archive
The findings prompt the researchers to consider whether car design might need to change to afford greater protection to the considerable proportion of obese people in the population - currently around a third of all US adults.
A new study by researchers at the University of Eastern Finland shows for the first time that blood-based measurement of glial fibrillary acidic protein (GFAP) enables distinguishing patients with frontotemporal dementia from those with primary psychiatric disorders or healthy individuals.
Los Angeles Association of Health Underwriters announces its annual Health Insurance Awareness Week. This week is set aside to perform outreach to the community in the form of health awareness and to the importance of the role of the health insurance agent.
Boston-based Veritas Genetics, a pioneer in accessible genetic screening for disease prevention and early detection, received its first European CE mark approval for the company's hereditary breast and ovarian cancer genetic screening test, myBRCA. Veritas introduced myBRCA, which sequences BRCA1 and BRCA2 genes using proprietary gene-targeting technology and Next Generation Sequencing, in North America in May 2015.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Raid Abu-awwad, MD Po Box 8035, Wichita, KS 67208-0035 Ph: (316) 689-9135 | Dr Raid Abu-awwad, MD 3311 E Murdock St, Wichita, KS 67208-3054 Ph: (316) 689-9325 |
News Archive
The findings prompt the researchers to consider whether car design might need to change to afford greater protection to the considerable proportion of obese people in the population - currently around a third of all US adults.
A new study by researchers at the University of Eastern Finland shows for the first time that blood-based measurement of glial fibrillary acidic protein (GFAP) enables distinguishing patients with frontotemporal dementia from those with primary psychiatric disorders or healthy individuals.
Los Angeles Association of Health Underwriters announces its annual Health Insurance Awareness Week. This week is set aside to perform outreach to the community in the form of health awareness and to the importance of the role of the health insurance agent.
Boston-based Veritas Genetics, a pioneer in accessible genetic screening for disease prevention and early detection, received its first European CE mark approval for the company's hereditary breast and ovarian cancer genetic screening test, myBRCA. Veritas introduced myBRCA, which sequences BRCA1 and BRCA2 genes using proprietary gene-targeting technology and Next Generation Sequencing, in North America in May 2015.
› Verified 1 days ago
Ahmad Qaddour, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 9300 E 29th St N, Suite 310, Wichita, KS 67226 Phone: 316-858-9000 Fax: 316-858-9005 | |
Kathryn Watkins Brickman, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 550 N Hillside St, Wichita, KS 67214 Phone: 316-962-2000 Fax: 303-306-7753 | |
Ray F Fisher, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 818 N Carriage Pkwy, Wichita, KS 67208 Phone: 316-651-2252 Fax: 316-651-2314 | |
Mitchell A Morgan, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1131 S Clifton Ave, Suite B, Wichita, KS 67218 Phone: 316-462-1040 Fax: 316-462-1042 | |
Dr. Kent B Murray, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 5500 E Kellogg Dr, Wichita, KS 67218 Phone: 316-651-3603 Fax: 316-651-6666 | |
Dr. Raghu C Chaparala, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2160 W 21st St N, Wichita, KS 67203 Phone: 316-267-7175 Fax: 316-425-7799 | |
Layne M Reusser, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 9350 E 35th St N, Ste 101, Wichita, KS 67226 Phone: 316-265-1308 Fax: 316-712-9286 |